Page last updated: 2024-08-24

valsartan and Chronic Kidney Failure

valsartan has been researched along with Chronic Kidney Failure in 42 studies

Research

Studies (42)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (4.76)18.2507
2000's22 (52.38)29.6817
2010's13 (30.95)24.3611
2020's5 (11.90)2.80

Authors

AuthorsStudies
Di, X; Fu, L; He, Y; Jin, Y; Liu, R; Qi, X; Wang, Y; Wang, Z; Zheng, L; Zhong, H1
Slomski, A1
Agostoni, P; Cimino, R; Ferrari, C; Mantegazza, V; Mapelli, M; Maragna, R; Pepi, M; Pontone, G1
Chen, Y; Han, X; Liu, J; Ma, Y; Xie, D; Xu, H1
Heyse, A; Mahieu, E; Manhaeghe, L; Van Durme, F; Vanfraechem, C1
Daimon, S; Maeda, K; Yasuda, M1
Barbera, V; Bellasi, A; Cozzolino, M; De Pascalis, A; Di Lullo, L; Floccari, F; Mudoni, A; Rivera, R; Ronco, C; Santoro, A; Verdesca, S1
Chen, XM; Huang, MJ; Li, P; Su, TY; Wang, Y; Wei, RB; Yang, Y1
Bian, A; Brown, NJ; Davies, S; Dikalova, A; Fogo, AF; Gamboa, JL; Ikizler, TA; Kaseda, R; Kon, V; Linton, MF; Tsuchida, Y; Yang, H; Zhang, L; Zhong, J1
Choovichian, P; Leelasiri, K; Satirapoj, B; Supasyndh, O1
Baigent, C; Haynes, R; Judge, P; Landray, MJ1
Brown, NJ; Gamboa, JL; Ikizler, TA; Pretorius, M; Sprinkel, KC1
Bethel, MA; Currie, G; Haffner, SM; Holman, RR; Holzhauer, B; McMurray, JJV1
Baier, M; Bambauer, R; Handrock, R; Kirchertz, EJ; Leidig, M; Leinung, D; Schmieder, RE; Szabã, T1
Galle, J1
Araki, R; Ikeda, N; Inoue, T; Kanno, Y; Shoda, J; Sugahara, S; Suzuki, H; Takenaka, T1
Azuma, K; Dejima, T; Ishigami, T; Kokuho, T; Masuda, S; Mitsuhashi, H; Okano, Y; Ozawa, M; Shigenaga, A; Sugano, T; Tamura, K; Tokita, Y; Toya, Y; Tsurumi-Ikeya, Y; Uchino, K; Umemura, S; Wakui, H1
Furuyama, M; Hashimoto, T; Hayasaka, K; Matsunaga, A; Ogino, D; Toyoda, K1
Ecder, T; Kashihara, N; Locatelli, F; Palmer, BF1
Choi, KH; Han, DS; Han, SH; Kang, EW; Kang, SW; Lee, HC; Yoo, TH; Yoon, HS; Yoon, SJ1
Hasegawa, H; Kobayashi, Y; Komuro, I; Kuwabara, Y; Mizuma, H; Narumi, H; Shindo, S; Takano, H1
Brown, NJ; Gamboa, JL; Ikizler, TA; Luther, JM; Pretorius, M; Todd-Tzanetos, DR; Yu, C1
Bassi, R; Caldara, R; De Cobelli, F; Del Maschio, A; Fiorina, P; Gremizzi, C; Mello, A; Perseghin, G; Secchi, A; Vergani, A1
Chen, Z; Li, CC; Liu, X; Lou, T; Peng, H; Wang, C; Ye, ZC; Zhang, J1
Krum, H; Martin, J1
Kanno, Y; Nakamoto, H; Okada, H; Sugahara, S; Suzuki, H1
Cooper, ME; Thomas, MC1
Delcroix, C; Ekhlas, A; Esnault, VL; Moutel, MG; Nguyen, JM1
Dilek, I; Dogan, E; Durmus, A; Erkoc, R; Sayarlioglu, H; Topal, C1
Iigaya, K; Kumagai, H; Onami, T; Saruta, T; Takimoto, C1
Averbukh, Z; Berman, S; Efrati, S; Galperin, E; Malcev, E; Manevits, E; Rosenberg, R; Weissgarten, J1
Aslam, S; Leone, A; Santha, T; Wilcox, C1
Zoccali, C1
Esaki, M; Fujiwara, H; Fujiwara, T; Kanamori, H; Kondo, T; Li, L; Li, Y; Maruyama, R; Minatoguchi, S; Miyata, S; Nakagawa, M; Ogino, A; Ohno, T; Okada, H; Takemura, G1
Acikel, C; Caglar, K; Cakir, E; Eyileten, T; Kurt, Y; Oguz, Y; Saglam, M; Sonmez, A; Tasar, M; Vural, A; Yenicesu, M; Yilmaz, MI1
Bünten, B; Grabensee, B; Németh, R; Plum, J2
Aldigier, JC; Botteri, F; Mann, JF; Oddou-Stock, P; Ponticelli, C; Ruilope, LM1
Ganten, D; Geiger, H; Hartner, A; Hilgers, KF; Hugo, C; Mai, M; Mann, JF; Porst, M; Veelken, R; Wittmann, M1
Coats, AJ1
Kozlovskaia, NL; Medvedeva, TIu; Miroshnichenko, NG; Okonova, EB; Plieva, OK; Rudenko, TE; Shonichev, DG; Shvetsov, MIu; Stavrovskaia, EV1

Reviews

9 review(s) available for valsartan and Chronic Kidney Failure

ArticleYear
[Neprilysin inhibition and chronic kidney disease].
    Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2017, Sep-28, Volume: 34, Issue:5

    Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Cardiovascular Diseases; Clinical Trials as Topic; Disease Progression; Diuresis; Drug Combinations; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic; Models, Biological; Molecular Targeted Therapy; Natriuresis; Natriuretic Peptides; Neprilysin; Proteinuria; Renal Insufficiency, Chronic; Renin-Angiotensin System; Tetrazoles; Valsartan

2017
Neprilysin inhibition in chronic kidney disease.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2015, Volume: 30, Issue:5

    Topics: Aminobutyrates; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Cardiovascular Diseases; Clinical Trials as Topic; Disease Progression; Drug Combinations; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic; Natriuresis; Nephrology; Neprilysin; Proteinuria; Pyridines; Renin-Angiotensin System; Tetrazoles; Thiazepines; Treatment Outcome; Valsartan

2015
Reduction of proteinuria with angiotensin receptor blockers.
    Nature clinical practice. Cardiovascular medicine, 2008, Volume: 5 Suppl 1

    Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Biomarkers; Cardiovascular Diseases; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan

2008
Renal protective effect of RAAS blockade across the renal continuum, with a review of the efficacy and safety of valsartan.
    Current medical research and opinion, 2009, Volume: 25, Issue:12

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cytoprotection; Humans; Hypertension; Hypertension, Renal; Kidney; Kidney Failure, Chronic; Models, Biological; Renin-Angiotensin System; Tetrazoles; Treatment Outcome; Valine; Valsartan

2009
Role of valsartan and other angiotensin receptor blocking agents in the management of cardiovascular disease.
    Pharmacological research, 2002, Volume: 46, Issue:3

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiac Output, Low; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Myocardial Infarction; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan

2002
Blockade of the renin-angiotensin system: better late than never.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2004, Volume: 43, Issue:6

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Diabetes Complications; Humans; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Peritoneal Dialysis, Continuous Ambulatory; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan

2004
[Molecular mechanisms underlying proteinuria reduction and protection of nephrin and podocytes by ARB].
    Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 2

    Topics: Actinin; Actins; Adaptor Proteins, Signal Transducing; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Cytoskeletal Proteins; Humans; Intracellular Signaling Peptides and Proteins; Kidney Failure, Chronic; Membrane Proteins; Podocytes; Proteins; Proteinuria; Receptor, Angiotensin, Type 1; Tetrazoles; Valine; Valsartan

2006
Asymmetric dimethylarginine in end-stage renal disease patients: a biomarker modifiable by calcium blockade and angiotensin II antagonism?
    Kidney international, 2006, Volume: 70, Issue:12

    Topics: Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Arginine; Biomarkers; Calcium; Calcium Channel Blockers; Humans; Kidney Failure, Chronic; Risk Factors; Tetrazoles; Valine; Valsartan

2006
Angiotensin receptor blockers -- finally the evidence is coming in: IDNT and RENAAL.
    International journal of cardiology, 2001, Volume: 79, Issue:2-3

    Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Diabetes Mellitus, Type 2; Humans; Hypertension; Irbesartan; Kidney Failure, Chronic; Losartan; Tetrazoles; Valine; Valsartan

2001

Trials

22 trial(s) available for valsartan and Chronic Kidney Failure

ArticleYear
Angiotensin receptor blocker vs ACE inhibitor effects on HDL functionality in patients on maintenance hemodialysis.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2018, Volume: 28, Issue:6

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Cholesterol, HDL; Double-Blind Method; Female; Humans; Inflammation Mediators; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Ramipril; Renal Dialysis; Tennessee; Time Factors; Treatment Outcome; Valsartan

2018
Short-term administration of an angiotensin II receptor blocker in patients with long-term hemodialysis patients improves insulin resistance.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2014, Volume: 97, Issue:6

    Topics: Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Glucose; Female; Humans; Insulin Resistance; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Renal Dialysis; Tetrazoles; Valine; Valsartan

2014
Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis--a randomized cross-over study.
    BMC nephrology, 2015, Oct-22, Volume: 16

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arginine; Bradykinin; Cell Line; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Ramipril; Renal Dialysis; Valsartan

2015
Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
    Diabetes, obesity & metabolism, 2017, Volume: 19, Issue:6

    Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Creatinine; Double-Blind Method; Female; Follow-Up Studies; Glucose Intolerance; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Valsartan

2017
Efficacy, safety and tolerability of valsartan 80 mg compared to irbesartan 150 mg in hypertensive patients on long-term hemodialysis (VALID study).
    Clinical nephrology, 2008, Volume: 69, Issue:6

    Topics: Aged; Antihypertensive Agents; Biphenyl Compounds; Cross-Over Studies; Female; Humans; Hypertension; Irbesartan; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Tetrazoles; Treatment Outcome; Valine; Valsartan

2008
Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: an open-label randomized controlled trial.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2008, Volume: 52, Issue:3

    Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Cardiovascular Diseases; Female; Humans; Incidence; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Renal Dialysis; Tetrazoles; Valine; Valsartan

2008
Effects of angiotensin II type 1 receptor blocker on blood pressure variability and cardiovascular remodeling in hypertensive patients on chronic peritoneal dialysis.
    Nephron. Clinical practice, 2009, Volume: 112, Issue:1

    Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Circadian Rhythm; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Natriuretic Peptides; Peritoneal Dialysis, Continuous Ambulatory; Pulse; Tetrazoles; Valine; Valsartan; Ventricular Remodeling

2009
Combined vascular effects of HMG-CoA reductase inhibitor and angiotensin receptor blocker in non-diabetic patients undergoing peritoneal dialysis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011, Volume: 26, Issue:11

    Topics: Angiotensin II Type 1 Receptor Blockers; Brachial Artery; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Prognosis; Prospective Studies; Tetrazoles; Valine; Valsartan; Vascular Resistance; Vascular Stiffness; Vasodilation

2011
Effects of valsartan and amlodipine on home blood pressure and cardiovascular events in Japanese hypertensive patients: a subanalysis of the VART.
    Journal of human hypertension, 2012, Volume: 26, Issue:11

    Topics: Aged; Albuminuria; Amlodipine; Angina Pectoris; Antihypertensive Agents; Asian People; Blood Pressure; Cardiovascular Diseases; Cause of Death; Creatinine; Death, Sudden; Female; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Stroke; Tetrazoles; Treatment Outcome; Valine; Valsartan

2012
Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis.
    Journal of the American Society of Nephrology : JASN, 2012, Volume: 23, Issue:2

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Coagulation; CD40 Ligand; Cross-Over Studies; Cytokines; Double-Blind Method; Female; Hemodynamics; Humans; Inflammation; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Ramipril; Renal Dialysis; Renin; Tetrazoles; Valine; Valsartan

2012
31P-magnetic resonance spectroscopy (31P-MRS) detects early changes in kidney high-energy phosphate metabolism during a 6-month Valsartan treatment in diabetic and non-diabetic kidney-transplanted patients.
    Acta diabetologica, 2012, Volume: 49 Suppl 1

    Topics: Adult; Angiotensin Receptor Antagonists; Female; Humans; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Magnetic Resonance Spectroscopy; Male; Middle Aged; Phosphates; Tetrazoles; Valine; Valsartan

2012
Effect of valsartan with bedtime dosing on chronic kidney disease patients with nondipping blood pressure pattern.
    Journal of clinical hypertension (Greenwich, Conn.), 2013, Volume: 15, Issue:1

    Topics: Adult; Analysis of Variance; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Chi-Square Distribution; Drug Chronotherapy; Echocardiography; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; Tetrazoles; Treatment Outcome; Valine; Valsartan

2013
Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2004, Volume: 43, Issue:6

    Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Creatinine; Female; Humans; Hypertension; Japan; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Cavity; Peritoneal Dialysis, Continuous Ambulatory; Prospective Studies; Proteinuria; Retrospective Studies; Tetrazoles; Urine; Valine; Valsartan

2004
Diuretic and enhanced sodium restriction results in improved antiproteinuric response to RAS blocking agents.
    Journal of the American Society of Nephrology : JASN, 2005, Volume: 16, Issue:2

    Topics: Adult; Aged; Antihypertensive Agents; Cross-Over Studies; Diet, Sodium-Restricted; Diuretics; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Prospective Studies; Proteinuria; Ramipril; Reference Values; Risk Assessment; Severity of Illness Index; Tetrazoles; Treatment Outcome; Valine; Valsartan

2005
Effect of valsartan on erythropoietin and hemoglobin levels in stage III-IV chronic kidney disease patients.
    International journal of clinical practice, 2005, Volume: 59, Issue:9

    Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Urea Nitrogen; Creatinine; Erythropoietin; Female; Follow-Up Studies; Glomerular Filtration Rate; Hemoglobins; Humans; Kidney Failure, Chronic; Male; Middle Aged; Potassium; Tetrazoles; Uric Acid; Valine; Valsartan

2005
Blockade of renin-angiotensin system reduces QT dispersion and improves intracellular Ca/Mg status in hemodialysis patients.
    Nephron. Clinical practice, 2006, Volume: 104, Issue:4

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Calcium; Cilazapril; Female; Heart Rate; Humans; In Vitro Techniques; Kidney Failure, Chronic; Magnesium; Male; Middle Aged; Renal Dialysis; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan

2006
Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis.
    Kidney international, 2006, Volume: 70, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Arginine; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Female; Humans; Hypertension, Renal; Kidney Failure, Chronic; Male; Methylation; Middle Aged; Oxidative Stress; Renal Dialysis; Tetrazoles; Valine; Valsartan

2006
Improving proteinuria, endothelial functions and asymmetric dimethylarginine levels in chronic kidney disease: ramipril versus valsartan.
    Blood purification, 2007, Volume: 25, Issue:4

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arginine; Biomarkers; Blood Glucose; C-Reactive Protein; Female; Glomerular Filtration Rate; Hemorheology; Humans; Insulin Resistance; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Proteinuria; Ramipril; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan; Vasodilation

2007
Effects of the angiotensin II antagonist valsartan on blood pressure, proteinuria, and renal hemodynamics in patients with chronic renal failure and hypertension.
    Journal of the American Society of Nephrology : JASN, 1998, Volume: 9, Issue:12

    Topics: Aged; Albuminuria; Angiotensin II; Antihypertensive Agents; Blood Pressure; Blood Urea Nitrogen; Creatinine; Dextrans; Double-Blind Method; Erythrocyte Count; Female; Glomerular Filtration Rate; Humans; Hypertension, Renal; Inulin; Kidney Failure, Chronic; Kidney Glomerulus; Male; Middle Aged; Molecular Weight; p-Aminohippuric Acid; Particle Size; Potassium; Prospective Studies; Proteinuria; Renal Circulation; Tetrazoles; Valine; Valsartan

1998
Treatment with the angiotensin II antagonist valsartan in patients with chronic renal failure and hypertension.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14 Suppl 4

    Topics: Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Renal Circulation; Tetrazoles; Valine; Valsartan

1999
Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Journal of hypertension, 2000, Volume: 18, Issue:1

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Creatinine; Drug Combinations; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Pilot Projects; Potassium; Proteinuria; Safety; Tetrazoles; Valine; Valsartan

2000
[Experience in the use of valsartan with the aim to inhibit progression of kidney failure in patients with chronic glomerulonephritis].
    Terapevticheskii arkhiv, 2001, Volume: 73, Issue:6

    Topics: Adult; Antihypertensive Agents; Chronic Disease; Female; Follow-Up Studies; Glomerulonephritis; Humans; Hypertension; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Proteinuria; Tetrazoles; Time Factors; Valine; Valsartan

2001

Other Studies

11 other study(ies) available for valsartan and Chronic Kidney Failure

ArticleYear
Simultaneous determination and pharmacokinetics study of valsartan, sacubitril and its major metabolite in human plasma, urine and peritoneal dialysis fluid in patients with end-stage renal disease by UPLC-MS/MS.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2022, Oct-01, Volume: 1208

    Topics: Aminobutyrates; Biphenyl Compounds; Chromatography, High Pressure Liquid; Chromatography, Liquid; Humans; Kidney Failure, Chronic; Peritoneal Dialysis; Tandem Mass Spectrometry; Valsartan

2022
Sacubitril-Valsartan and Heart Function in End-stage Kidney Disease.
    JAMA, 2022, 10-25, Volume: 328, Issue:16

    Topics: Aminobutyrates; Biphenyl Compounds; Cardiovascular Agents; Drug Combinations; Heart Failure; Humans; Kidney Failure, Chronic; Stroke Volume; Valsartan

2022
Dramatic disease regression in a case of HFrEF with end-stage renal failure treated with sacubitril/valsartan and SGLT2i.
    ESC heart failure, 2023, Volume: 10, Issue:3

    Topics: Female; Heart Failure; Humans; Kidney Failure, Chronic; Renal Insufficiency, Chronic; Stroke Volume; Tetrazoles; Valsartan

2023
Angiopoietin-like protein 3 deficiency combined with valsartan administration protects better against podocyte damage in streptozotocin-induced diabetic nephropathy mice.
    International immunopharmacology, 2023, Volume: 115

    Topics: Angiopoietin-Like Protein 3; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney Failure, Chronic; Mice; Podocytes; Reactive Oxygen Species; Streptozocin; Valsartan

2023
Sacubitril/valsartan in heart failure and end-stage renal insufficiency.
    ESC heart failure, 2019, Volume: 6, Issue:6

    Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Drug Combinations; Heart Failure; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Tetrazoles; Valsartan

2019
Effect of sacubitril-valsartan on cardiac function in hemodialysis patients.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2022, Volume: 26, Issue:1

    Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Drug Combinations; Heart Failure; Humans; Kidney Failure, Chronic; Pilot Projects; Renal Dialysis; Treatment Outcome; Valsartan; Ventricular Function, Left

2022
Valsartan Alleviates Insulin Resistance in Skeletal Muscle of Chronic Renal Failure Rats.
    Medical science monitor : international medical journal of experimental and clinical research, 2018, Apr-21, Volume: 24

    Topics: Angiotensin II; Animals; Cell Line; Glucose; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Kidney Failure, Chronic; Male; Muscle, Skeletal; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; Valsartan

2018
Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy.
    Clinical and experimental nephrology, 2009, Volume: 13, Issue:6

    Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Apolipoproteins E; Bezafibrate; Child; Child, Preschool; Enalapril; Female; Hematuria; Humans; Hypolipidemic Agents; Kidney Diseases; Kidney Failure, Chronic; Kidney Glomerulus; Nephrotic Syndrome; Probucol; Tetrazoles; Valine; Valsartan

2009
[Type 2 diabetic patient with kidney damage. Sartans banish dialysis risk].
    MMW Fortschritte der Medizin, 2004, Jul-08, Volume: 146, Issue:27-28

    Topics: Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Randomized Controlled Trials as Topic; Renal Dialysis; Tetrazoles; Valine; Valsartan

2004
Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure.
    Journal of cardiac failure, 2007, Volume: 13, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Urea Nitrogen; Blotting, Western; Creatinine; Disease Models, Animal; DNA; Heart Failure; Immunohistochemistry; Kidney Failure, Chronic; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Nephrectomy; Oxidative Stress; Receptor, Angiotensin, Type 1; Signal Transduction; Tetrazoles; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1; Treatment Outcome; Up-Regulation; Valine; Valsartan; Ventricular Function, Left

2007
Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury.
    Kidney international, 2000, Volume: 58, Issue:6

    Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Chemokine CCL2; Chemotaxis, Leukocyte; Gene Expression; Hypertension, Renal; Kidney; Kidney Failure, Chronic; Macrophages; Monocytes; Nephrosclerosis; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Mutant Strains; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Valine; Valsartan

2000